Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,300
Closed -$663K 229
2025
Q4
$663K Buy
6,300
+3,700
+142% +$347K 0.42% 49
2025
Q3
$218K Buy
+2,600
New +$214K 0.11% 113
2025
Q2
Sell
-6,600
Closed -$592K 150
2025
Q1
$592K Sell
6,600
-1,100
-14% -$103K 0.17% 106
2024
Q4
$766K Buy
7,700
+2,200
+40% +$227K 0.37% 66
2024
Q3
$625K Buy
+5,500
New +$653K 0.21% 71

Other funds holding MRK

XY Capital's MRK Position: Q2 2025 in Review

XY Capital sold out of Merck (MRK) in Q2 2025, closing a stake of 2,223 shares — an estimated $200K sold.

XY Capital first reported a position in MRK in Q3 2024 and held it in 3 quarters. The position peaked at $211K in Q3 2024. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • XY Capital reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • XY Capital sold 2,223 Merck shares in Q2 2025, an estimated $200K.
  • XY Capital first reported a position in Merck in Q3 2024 and held it in 3 quarters.
  • XY Capital's Merck position peaked at $211K in Q3 2024.
  • 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on XY Capital's 13F filing for Q2 2025, filed 14 Aug 2025.